CD248(+) stromal cells are associated with progressive chronic kidney disease

Stuart Smith, KS Eardley, Adam Croft, J Nwosu, AJ Howie, Paul Cockwell, CM Isacke, Christopher Buckley, Caroline Savage

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)
13 Downloads (Pure)

Abstract

Stromal fibroblasts are the primary cells of the kidney that produce fibrotic matrix. CD248 is a stromal marker expressed on fibroblasts and pericytes within the human kidney. Here, we tested whether CD248 expression in the kidney colocalizes with fibrosis and if it is associated with known determinants of chronic kidney disease (CKD). CD248 expression was located and quantified in situ by immunohistochemistry in kidney biopsies from 93 patients with IgA nephropathy and compared with 22 archived biopsies encompassing normal kidney tissue as control. In normal kidney tissue, CD248 was expressed by resident pericytes, stromal fibroblasts, and was upregulated in human CKD. The expression was linked to known determinants of renal progression. This relationship was maintained in a multivariate analysis with CD248 expression linked to renal survival. CD248 was expressed by a population of α-smooth muscle actin (SMA)(+) myofibroblasts and α-SMA(-) stromal cells but not expressed on CD45(+) leukocytes. Thus, CD248 defines a subset of stromal cells, including but not limited to some myofibroblasts, linked to albuminuria and tubulointerstitial damage during tissue remodeling in CKD.Kidney International advance online publication, 13 April 2011; doi:10.1038/ki.2011.103.
Original languageEnglish
Pages (from-to)199-207
Number of pages9
JournalKidney International
Volume80
DOIs
Publication statusPublished - 13 Apr 2011

Fingerprint

Dive into the research topics of 'CD248(+) stromal cells are associated with progressive chronic kidney disease'. Together they form a unique fingerprint.

Cite this